ALPS Advisors’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-56,619
Closed -$3.11M 1028
2025
Q3
$3.11M Sell
56,619
-7,773
-12% -$320K 0.02% 321
2025
Q2
$2.13M Buy
+64,392
New +$2.24M 0.01% 359
2023
Q2
Sell
-62,694
Closed -$2.21M 1011
2023
Q1
$2.21M Sell
62,694
-1,433
-2% -$58.5K 0.02% 268
2022
Q4
$2.94M Buy
64,127
+12,727
+25% +$548K 0.03% 235
2022
Q3
$2.49M Buy
51,400
+588
+1% +$28.3K 0.02% 265
2022
Q2
$2M Sell
50,812
-35,396
-41% -$1.43M 0.02% 320
2022
Q1
$3.17M Sell
86,208
-10,863
-11% -$386K 0.03% 158
2021
Q4
$4.42M Sell
97,071
-5,283
-5% -$204K 0.05% 157
2021
Q3
$3.66M Buy
102,354
+7,862
+8% +$231K 0.04% 195
2021
Q2
$1.87M Sell
94,492
-34,160
-27% -$802K 0.02% 335
2021
Q1
$2.99M Buy
128,652
+1,214
+1% +$25.9K 0.03% 217
2020
Q4
$2.65M Buy
+127,438
New +$2.33M 0.03% 232

Other funds holding CYTK